Modulating ongoing Th2-cell responses in experimental leishmaniasis
- 28 February 1997
- journal article
- review article
- Published by Elsevier in Parasitology Today
- Vol. 13 (2), 76-79
- https://doi.org/10.1016/s0169-4758(96)10078-8
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Successful Chemotherapy in Experimental Leishmaniasis Is Influenced by the Polarity of the T Cell Response Before TreatmentThe Journal of Infectious Diseases, 1996
- T-cell proliferation to subinfectious SIV correlates with lack of infection after challenge of macaquesAIDS, 1994
- Role of cytokines in determining T-lymphocyte functionCurrent Opinion in Immunology, 1994
- Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response.The Journal of Experimental Medicine, 1993
- Establishment of Stable, Cell-Mediated Immunity that Makes "Susceptible" Mice Resistant to Leishmania majorScience, 1992
- Visceral leishmaniasisAIDS, 1991
- Requirement for T cells and effect of lymphokines in successful chemotherapy for an intracellular infection. Experimental visceral leishmaniasis.Journal of Clinical Investigation, 1989
- Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets.The Journal of Experimental Medicine, 1989
- Visceral leishmaniasis in immunocompromised hostsThe American Journal of Medicine, 1987
- An in Vitro Model for Investigation of Chemotherapeutic Agents in LeishmaniasisThe Journal of Infectious Diseases, 1980